Onji M - Search Results

1

Obesity and gastrointestinal liver disorders in Japan.

Matsuura B, Nunoi H, Miyake T, Hiasa Y, Onji M. Matsuura B, et al. Among authors: onji m. J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:48-53. doi: 10.1111/jgh.12238. J Gastroenterol Hepatol. 2013. PMID: 24251704 Review.

2

Etiology of liver cirrhosis in Japan: a nationwide survey.

Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M; Japan Etiology of Liver Cirrhosis Study Group. Michitaka K, et al. Among authors: onji m. J Gastroenterol. 2010;45(1):86-94. doi: 10.1007/s00535-009-0128-5. Epub 2009 Sep 30. J Gastroenterol. 2010. PMID: 19789837

3

Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.

Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Hiraoka A, et al. Among authors: onji m. J Gastroenterol Hepatol. 2010 Feb;25(2):403-7. doi: 10.1111/j.1440-1746.2009.06037.x. Epub 2009 Nov 19. J Gastroenterol Hepatol. 2010. PMID: 19929922

4

Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease.

Miyake T, Akbar SM, Yoshida O, Chen S, Hiasa Y, Matsuura B, Abe M, Onji M. Miyake T, et al. Among authors: onji m. J Gastroenterol. 2010 Aug;45(8):859-67. doi: 10.1007/s00535-010-0218-4. Epub 2010 Mar 2. J Gastroenterol. 2010. PMID: 20195647

5

Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.

Miyake T, Kumagi T, Hirooka M, Koizumi M, Furukawa S, Ueda T, Tokumoto Y, Ikeda Y, Abe M, Kitai K, Hiasa Y, Matsuura B, Onji M. Miyake T, et al. Among authors: onji m. J Gastroenterol. 2012 Jun;47(6):696-703. doi: 10.1007/s00535-012-0534-y. Epub 2012 Feb 14. J Gastroenterol. 2012. PMID: 22331365

6

Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Miyake T, Kumagi T, Hirooka M, Furukawa S, Koizumi M, Tokumoto Y, Ueda T, Yamamoto S, Abe M, Kitai K, Hiasa Y, Matsuura B, Onji M. Miyake T, et al. Among authors: onji m. J Gastroenterol. 2013 Mar;48(3):413-22. doi: 10.1007/s00535-012-0650-8. Epub 2012 Aug 31. J Gastroenterol. 2013. PMID: 22933183

7

Non-alcoholic fatty liver disease: factors associated with its presence and onset.

Miyake T, Kumagi T, Furukawa S, Tokumoto Y, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M. Miyake T, et al. Among authors: onji m. J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:71-8. doi: 10.1111/jgh.12251. J Gastroenterol Hepatol. 2013. PMID: 24251708 Review.

8

B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease.

Miyake T, Abe M, Tokumoto Y, Hirooka M, Furukawa S, Kumagi T, Hamada M, Kawasaki K, Tada F, Ueda T, Hiasa Y, Matsuura B, Onji M. Miyake T, et al. Among authors: onji m. Hepatol Int. 2013 Jun;7(2):539-47. doi: 10.1007/s12072-012-9345-8. Epub 2012 Feb 9. Hepatol Int. 2013. PMID: 26201785

9

Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.

Matsuura B, Kanno S, Minami H, Tsubouchi E, Iwai M, Matsui H, Horiike N, Onji M. Matsuura B, et al. Among authors: onji m. J Gastroenterol. 2004;39(4):339-45. doi: 10.1007/s00535-003-1300-y. J Gastroenterol. 2004. PMID: 15168245

10

[Clinical features and pathogenesis of fulminant hepatitis caused by HAV].

Hiasa Y, Onji M. Hiasa Y, et al. Among authors: onji m. Nihon Rinsho. 2004 Aug;62 Suppl 8:478-82. Nihon Rinsho. 2004. PMID: 15453369 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page